Calumet (CLMT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
18 May, 2026Executive summary
Achieved net income of $313.4 million and basic EPS of $3.61 for Q3 2025, a turnaround from a net loss of $100.6 million in Q3 2024, driven by RINs Obligation de-recognition, improved margins, and strong specialty and renewables performance.
Adjusted EBITDA with Tax Attributes reached $92.5 million, up from $59.8 million year-over-year, reflecting record specialty production and margin gains.
Company-wide cost reduction initiatives delivered $61 million in operating cost savings year-to-date, with quarterly operating costs down $24 million versus last year.
Montana Renewables is on track for 120–150 million gallons of annualized SAF production by Q2 2026, with 100 million gallons already committed or in advanced contracting.
Completed C-Corp conversion in July 2024 and divested Royal Purple Industrial business, recording a $55.8 million gain.
Financial highlights
Q3 2025 sales were $1,078.0 million, slightly down from $1,100.4 million in Q3 2024; gross profit rose to $373.7 million from $4.9 million.
Specialty Products & Solutions Adjusted EBITDA was $80.2 million, up from $50.7 million, with margin improvement to 11.8%.
Montana/Renewables Adjusted EBITDA with Tax Attributes was $17.1 million, up from $14.6 million, benefiting from cost reductions and regulatory relief.
Reduced restricted group debt by over $40 million during the quarter, with net recourse debt at $1,129.4 million as of Q3 2025.
Cash and cash equivalents at September 30, 2025 were $94.6 million, with total liquidity of $384.4 million.
Outlook and guidance
Montana Renewables' SAF expansion is expected online in Q2 2026, with strong premium contracting and robust demand.
Continued focus on cost discipline, deleveraging, and operational improvements to drive further margin gains.
Management expects continued strong demand and margin environment for specialty and fuel products into Q4 2025, with some seasonal weakness.
Anticipate industry margin recovery in 2026 as RVO finalization lifts sector profitability.
2025 capital expenditures forecasted at $60–90 million, excluding MaxSAF project spending.
Latest events from Calumet
- Board refreshed, financials strong, and all proposals approved as growth initiatives advance.CLMT
AGM 20262 Jun 2026 - 2025 saw strong revenue, debt reduction, and major renewables growth; board urges support for all proposals.CLMT
Proxy filing18 May 2026 - Strong 2024 results, C-Corp conversion, and major SAF expansion drive governance and compensation focus.CLMT
Proxy filing18 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Q1 2026 Adjusted EBITDA with Tax Attributes was $50.1M; expansion and supply deals support growth.CLMT
Q1 202618 May 2026 - Adjusted EBITDA up 30% to $293.3M, $222M debt cut, and record specialty output achieved.CLMT
Q4 20257 Apr 2026 - Expanding SAF production and strong cash flow drive growth, supported by regulatory tailwinds.CLMT
H.C. Wainwright Renewables Fuels Virtual Day presentation25 Mar 2026 - Q2 2024 delivered $66.8M EBITDA, record volumes, and C-Corp conversion amid margin pressure.CLMT
Q2 20241 Feb 2026